Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.
Frank Rimerman Advisors LLC slashed its Amgen holdings by 66.2% last quarter, parting with 9,031 shares and retaining only ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Choate Investment Advisors trimmed its stake in Amgen Inc. by 9.0% during Q4, selling 1,579 shares and holding 15,990 shares worth $4.17 million. Meanwhile, other major institutional investors, like ...
DelveInsight's "EMPAVELI Market Size, Forecast, and Market Insight Report" highlights the details around EMPAVELI, a ...
EDT Regeneron (REGN) down 3% after appeals court decision in Amgen (AMGN) patent fightLight Up your Portfolio with Spark:Easily identify ...
The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...
Most organizations have some type of multifunctional committee set up to evaluate generative AI applications. Those ...
Most organizations have some type of multi-functional committee set up to evaluate generative AI applications. Those ...
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...
Oncolytics Biotech Inc. (NASDAQ: ONCY ... in LGSOC and a collaboration with Amgen to evaluate its therapy in combination with LUMAKRAS™ for KRAS G12C mutant lung cancer. While all information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback